Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04117347 · ClinicalTrials.gov registry record · NA
Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04117347 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 50 participants.
The verdict
NCT04117347, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of different amounts of time of morning light on brain emotional processing.
Interventions
- DEVICE Light therapy A via the Re-Timer®
- DEVICE Light therapy B via the Re-Timer®
- DEVICE Light therapy C via the Re-Timer®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-01-24 |
| Est. Completion | 2023-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04117347
The ClinicalTrials.gov registry entry for NCT04117347 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Light therapy A via the Re-Timer® is the first listed.
NCT04117347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04117347 about?
NCT04117347 is a clinical study titled "Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity". The purpose of this study is to determine the effect of different amounts of time of morning light on brain emotional processing.
What is the current status of trial NCT04117347?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-01-24. Estimated completion is 2023-03-08.
What interventions are being tested in trial NCT04117347?
The interventions under investigation include: Light therapy A via the Re-Timer® (DEVICE), Light therapy B via the Re-Timer® (DEVICE), Light therapy C via the Re-Timer® (DEVICE).
Who is sponsoring clinical trial NCT04117347?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.